계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
LEAH Labs
company
About
LEAH Labs provides Car T cells for curing B-cell lymphoma cancer in dogs .
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $225K
- Industries
- Biotechnology,Health Care,Product Research
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
LEAH Labs provides Car T cells for curing B-cell lymphoma cancer in dogs.Scientists at LEAH Labs use precision gene editing to reprogram T immune cells with Chimeric Antigen Receptors (CAR) in order to create CAR T cells that seek out, specifically recognize, and destroy B cell lymphoma without the off-target side effects that come with chemotherapy.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$325K
LEAH Labs has raised a total of
$325K
in funding over 2 rounds. Their latest funding was raised on
May 10, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 10, 2022 | Grant | $100K | 1 | — | — | Detail |
| May 8, 2020 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
LEAH Labs is funded by 2 investors.
National Science Foundation
and Regenerative Medicine Minnesota
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Regenerative Medicine Minnesota
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
